The backlash over high drug prices is hitting pharma where it hurts

(By Meghana Keshavan for STAT)

The simmering public outrage over drug prices finally seems to be catching up to the pharmaceutical industry. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.